Cargando…
Novel RAAS agonists and antagonists: clinical applications and controversies
The renin–angiotensin–aldosterone system (RAAS) regulates blood pressure homeostasis and vascular injury and repair responses. The RAAS was originally thought to be an endocrine system critically important in regulating blood pressure homeostasis. Yet, important local forms of the RAAS have been des...
Autores principales: | Romero, Cesar A., Orias, Marcelo, Weir, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097622/ https://www.ncbi.nlm.nih.gov/pubmed/25666495 http://dx.doi.org/10.1038/nrendo.2015.6 |
Ejemplares similares
-
The RAAS Goodfellas in Cardiovascular System
por: Caputo, Ilaria, et al.
Publicado: (2023) -
Development and Application of RAA Nucleic Acid Test Strip Assay and Double RAA Gel Electrophoresis Detection Methods for ASFV and CSFV
por: Wu, Keke, et al.
Publicado: (2022) -
RAAS inhibition and mortality in hypertension
por: Ferrari, Roberto
Publicado: (2013) -
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
por: Bozkurt, Biykem, et al.
Publicado: (2020) -
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities
por: Wang, James Jiqi, et al.
Publicado: (2020)